Literature DB >> 7493027

Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene.

P J Biggs1, R Wooster, D Ford, P Chapman, J Mangion, Y Quirk, D F Easton, J Burn, M R Stratton.   

Abstract

The human skin is a complex organ composed of the surface epidermis, the subjacent dermis (in which blood vessels, lymphatics and nerves are located) and the skin appendages. The latter include hair follicles, sebaceous glands (which secrete lipids that may serve as a permeability barrier, emollient or antimicrobial agent), apocrine glands (which secrete scents) and eccrine glands (which produce sweat for temperature control). Hereditary cylindromatosis (MIM 123850) is a rare autosomal dominant disease characterised by the development of multiple neoplasms originating from the skin appendages. These neoplasms have been termed cylindromas due to their characteristic microscopic architecture and are believed to exhibit apocrine or eccrine differentiation. We have carried out a genome search using two families with this disease, which has provided strong evidence for linkage of cylindromatosis to loci on chromosome 16q12-q13. Using markers close to the cylindromatosis gene, consistent loss of the wild-type allele was observed in 19 tumours from four individuals in the two families, indicating that the gene is likely to be a tumour suppressor gene.

Entities:  

Mesh:

Year:  1995        PMID: 7493027     DOI: 10.1038/ng1295-441

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  25 in total

1.  [Treatment of recalcitrant wounds with autologous epidermal equivalents. After excision of multiple cylindromas of the scalp].

Authors:  A-K Tausche; G Richter-Huhn; G Sebastian
Journal:  Hautarzt       Date:  2004-03       Impact factor: 0.751

Review 2.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.

Authors:  Qian Zhang; Michael J Lenardo; David Baltimore
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

3.  [Cylindromatosis].

Authors:  H Dräger; R Kruse; J Reifenberger; U Meyer; K-W Schulte
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

4.  Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.

Authors:  Jun Zhang; Brigid Stirling; Stephane T Temmerman; Chi A Ma; Ivan J Fuss; Jonathan M J Derry; Ashish Jain
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

Review 5.  CYLD-mediated signaling and diseases.

Authors:  Bryan J Mathis; Yimu Lai; Chen Qu; Joseph S Janicki; Taixing Cui
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

6.  Epidermal CYLD inactivation sensitizes mice to the development of sebaceous and basaloid skin tumors.

Authors:  Yingai Jane Jin; Sally Wang; Joshua Cho; M Angelica Selim; Tim Wright; George Mosialos; Jennifer Y Zhang
Journal:  JCI Insight       Date:  2016-07-21

Review 7.  Genetics of skin appendage neoplasms and related syndromes.

Authors:  D A Lee; M E Grossman; P Schneiderman; J T Celebi
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

8.  Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.

Authors:  N Leonard; R Chaggar; C Jones; M Takahashi; A Nikitopoulou; S R Lakhani
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

9.  The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer.

Authors:  Jennifer Y Zhang; Maria Angelica Selim
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

10.  Familial cylindromatosis mimicking tuberous sclerosis complex and confirmation of the cylindromatosis locus, CYLD1, in a large family.

Authors:  S Verhoef; C T Schrander-Stumpel; V D Vuzevski; A Tempelaars; L A Jansen; G A Malfeyt; T L Ceelen; D Lindhout; D J Halley; A M van den Ouweland
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.